01 January 2001
NCX4016 (NO-aspirin) inhibits thromboxane biosynthesis and tissue factor expressionand activity in human monocytes.
Pietro Minuz, Maurizio Degan, Stefania Gaino, Alessandra Meneguzzi, Valeria Zuliani, Clara Lechi Santonastaso, Piero Del Soldato, Alessandro LechiMed Sci Monit 2001; 7(4): BR573-577 :: ID: 421101
Abstract
BACKGROUND: NCX4016 (2 acetoxy-benzoate 2-(2-nitroxymethyl)-phenyl ester,NicOx S.A., France) is an antithrombotic agent chemically related to acetylsalicylic acid (ASA). We hypothesisedthat NCX4016, being able to release nitric oxide (NO) and to inhibit cyclo-oxygenase, might inhibit theprothrombotic function in human monocytes.MATERIAL AND METHODS: The effects of NCX4016 and ASA on therelease of thromboxane (TX) B2 and tissue factor expression and activity were compared using adherenthuman monocytes. The tested drugs were added before stimulation with 10 Kg/ml LPS and incubation lasted6 hours. TXB2 concentration was measured by RIA in the supernatant of cultured cells. Immunoreactivetissue factor (TF) concentration was determined by enzyme-linked immunoassay and TF activity was assayedby measuring the peptidyl activity of the tissue factor/ factor VII complex.RESULTS: Both ASA and NCX401610-300 Kmol/L dose-dependently reduced TXB2 release. NCX4016 activity was comparable to that of equimolarASA. Part of the activity of NCX4016 up to 100 Kmol/L was prevented by 10 Kml/L ODQ, inhibitor of cGMPgeneration. Immunoreactive TF was dose-dependently inhibited by 300 Kmol/L NCX4016, but not by ASA. Alsotissue TF activity was reduced by 300 Kmol/L NCX4016, but not by ASA.CONCLUSIONS: The present resultsindicate that NCX4016 not only has anti-platelet effects but also inhibits prothrombotic activities inhuman monocytes, partly via NO-dependent mechanisms. NCX4016 may prove effective in the clinical settingof athero-thrombosis.
Keywords: Aspirin, Monocytes, Nitric Oxide Donors, Nitroso Compounds, Platelet Aggregation Inhibitors, Thromboplastin, Thromboxane B2
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
05 Mar 2024 : Clinical Research
Role of Critical Shoulder Angle in Degenerative Type Rotator Cuff Tears: A Turkish Cohort StudyMed Sci Monit In Press; DOI: 10.12659/MSM.943703
06 Mar 2024 : Clinical Research
Comparison of Outcomes between Single-Level and Double-Level Corpectomy in Thoracolumbar Reconstruction: A ...Med Sci Monit In Press; DOI: 10.12659/MSM.943797
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952